Toggle navigation
Menu
About Us
Investment Strategy
Team
Portfolio
News
Contact Us
Limited Partners
Portfolio
Entellus Medical Inc
Leading provider of devices for minimally invasive sinus surgery
Plymouth, MN
NASDAQ: ENTL
Contact:
Guido J. Neels
IPO
Acquisition
Acquired by: Stryker
Exit date: February 28, 2018
Related News
Centers for Medicare/Medicaid Services Establishes Coding and Payment for Eustachian Tube Balloon
Entellus Medical Announces Presentation of Positive Clinical Results in Pediatric Patients
Entellus Medical Announces Collaboration with Fiagon
Entellus Medical Announces Positive 24 Month Data from Remodel Trial, Meta-Analysis Across 6 Studies
Entellus Medical Announces European Launch of XprESS (TM) LoProfile Multi-Sinus Dilation System
Entellus Medical Announces Promotion Of Robert White To Chief Executive Officer
Entellus Medical Announces Fourth Quarter and Full Year 2014 Financial Results
Entellus Medical, Inc. Announces Pricing of Initial Public Offering
Entellus Medical Inc. Completes Series E Financing Totaling $35 Million
Study Shows That Employee Chronic Sinusitis Sufferers and Their Employers Benefit from Balloon Dilation of Sinus Drainage Pathways